Sex, gender, and health biotechnology: points to consider
AuthorSingh, JA; Bandewar, S; Singer, PA
Source TitleBMC International Health and Human Rights
PublisherBIOMED CENTRAL LTD
University of Melbourne Author/sSinger, Peter
AffiliationSchool of Historical and Philosophical Studies
Document TypeJournal Article
CitationsSingh, J. A., Bandewar, S. & Singer, P. A. (2009). Sex, gender, and health biotechnology: points to consider. BMC INTERNATIONAL HEALTH AND HUMAN RIGHTS, 9 (1), https://doi.org/10.1186/1472-698X-9-15.
Access StatusOpen Access
BACKGROUND: Reproductive technologies have been extensively debated in the literature. As well, feminist economists, environmentalists, and agriculturalists have generated substantial debate and literature on gender. However, the implications for women of health biotechnologies have received relatively less attention. Surprisingly, while gender based frameworks have been proposed in the context of public health policy, practice, health research, and epidemiological research, we could identify no systematic framework for gender analysis of health biotechnology in the developing world. DISCUSSION: We propose sex and gender considerations at five critical stages of health biotechnology research and development: priority setting; technology design; clinical trials; commercialization, and health services delivery. SUMMARY: Applying a systematic sex and gender framework to five key process stages of health biotechnology research and development could be a first step towards unlocking the opportunities of this promising science for women in the developing world.
- Click on "Export Reference in RIS Format" and choose "open with... Endnote".
- Click on "Export Reference in RIS Format". Login to Refworks, go to References => Import References